Streetwise Reports' Article Archives — February 2025 back to current month (9)
Virtual Healthcare Breakthrough Expanding Access for 6.9M Medicaid Patients in New York (02/27/2025)
Rocket Doctor, under Treatment.com AI Inc. (TRUE:CSE; TREIF:OTCMKTS; 939:FRA), is now an in-network provider for New York Medicaid, expanding virtual healthcare access to 6.9 million beneficiaries. Find out how this milestone offers the possibility to reshape healthcare accessibility.
DMT Study Set To Explore Breakthrough Potential in Stroke Recovery (02/14/2025)
Algernon Pharmaceuticals Inc. (AGN:CSE; AGNPF:OTCQB; AGW0:XFRA) subsidiary Algernon NeuroScience has appointed Dr. Sandor Nardai as Principal Investigator for its upcoming Phase 2a DMT stroke study. Find out how this trial could reshape stroke recovery research.
Healthcare Tech Co. To Acquire Digital Health Platform (02/13/2025)
This will expand its ecosystem of AI-powered products. Read on to learn more about its offerings and rapidly growing sector.
New Strategic Moves Aim To Accelerate Growth in AI Healthcare (02/12/2025)
Light AI Inc. (ALGO:CBOE) announces major marketing campaigns, advisory board appointments, and a key regulatory partnership to drive growth. Discover how these strategic moves could shape the future of AI healthcare.
Kentucky Medical Co. Has Strong Operating Fundamentals (02/12/2025)
Quipt Home Medical Corp. (QIPT:NASDAQ; QIPT:TSX.V) received a lowered price target but a Buy rating from a Leede Financial Inc. research note.
AI Stock in an Uptrend That Is Likely To Continue (02/10/2025)
Technical Analyst Clive Maund explains why he thinks Light AI Inc. (ALGO:CBOE) is an Immediate Strong Buy.
Healthcare Pioneer Expands Revolutionary Treatment Platform (02/06/2025)
Leading regenerative medicine company Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) says it has submitted an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for its Cell Pouch technology. One analyst says it is the "most advanced encapsulation device in development."
Biotech Requests OK to Assess Device in Second Indication (02/06/2025)
The company behind this possible "pipeline in a device" wants to evaluate it now in thyroid disease after having begun with trials in type 1 diabetes, noted an H.C. Wainwright & Co. report.
Biotherapeutic Co. Offers Potential Curative Alternative For Thyroid Disease (02/04/2025)
Sernova Biotherapeutics Inc. (SVA:TSX.V; SEOVF:OTCQB; PSH:XETRA) recently filed a new IND for Cell Pouch in thyroid disease. Read on to see what rating and target price Leede Financial Inc. gave this company.
More Archives
2024Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2023Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
2022Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec
